Chronic Pelvic Pain Syndrome: Clinical Trials

3 trials for Chronic Pelvic Pain Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Terminated 1

Follow Chronic Pelvic Pain Syndrome: new trials by email Literature Review of Chronic Pelvic Pain Syndrome trials Research Report on Chronic Pelvic Pain Syndrome

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vaginal Baclofen Suppositories in Chronic Pelvic Pain
20 mg baclofen vaginal suppository daily per vagina, Placebo - Chronic Pelvic Pain Syndrome
Phase 2CompletedUniversity of Louisville392024-01-012026-05-01
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
AQX-1125 200 mg, Placebo - Chronic Prostatitis, Chronic Pelvic Pain Syndrome
Phase 2TerminatedAquinox Pharmaceuticals (Canada) Inc.32018-04-182019-01-09
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
ASP3652, Placebo - Chronic Abacterial Prostatitis, Chronic Pelvic Pain Syndrome
Phase 2CompletedAstellas Pharma Inc2392011-06-012013-03-21

Narrower conditions

Bronchiolitis Obliterans Syndrome (1)  ·  Pelvic Pain (1)  ·  Prostatitis (1)

Broader conditions

Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Graft vs Host Disease (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Male Urogenital Diseases (1)  ·  Neurologic Manifestations (1)  ·  Organizing Pneumonia (1)  ·  Pain (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol (1)  ·  ASP3652 (1)

Sponsors

Aquinox Pharmaceuticals (Canada) Inc. (1)  ·  Astellas Pharma Inc (1)  ·  University of Louisville (1)

Countries

United States (2)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Daniel Shoskes, MD (1)  ·  Rodger W Rothenberger, MD (1)

Results publications

PMID 30178528